ZA972292B - Cytomegalovirus inhibiting compounds. - Google Patents
Cytomegalovirus inhibiting compounds.Info
- Publication number
- ZA972292B ZA972292B ZA9702292A ZA972292A ZA972292B ZA 972292 B ZA972292 B ZA 972292B ZA 9702292 A ZA9702292 A ZA 9702292A ZA 972292 A ZA972292 A ZA 972292A ZA 972292 B ZA972292 B ZA 972292B
- Authority
- ZA
- South Africa
- Prior art keywords
- cytomegalovirus
- inhibiting compounds
- compounds
- cmv
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9605437.4A GB9605437D0 (en) | 1996-03-15 | 1996-03-15 | Cytomegalovirus inhibiting compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA972292B true ZA972292B (en) | 1997-10-16 |
Family
ID=10790420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9702292A ZA972292B (en) | 1996-03-15 | 1997-03-17 | Cytomegalovirus inhibiting compounds. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0984967B1 (xx) |
JP (1) | JP2001515464A (xx) |
CN (1) | CN1069643C (xx) |
AT (1) | ATE260279T1 (xx) |
AU (1) | AU722650B2 (xx) |
BR (1) | BR9708068A (xx) |
CA (1) | CA2250320A1 (xx) |
DE (1) | DE69727838D1 (xx) |
GB (2) | GB9605437D0 (xx) |
TW (1) | TW480258B (xx) |
WO (1) | WO1997034894A1 (xx) |
ZA (1) | ZA972292B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9711257D0 (en) | 1997-05-30 | 1997-07-30 | Smithkline Beecham Plc | Novel compounds |
ATE249219T1 (de) * | 1997-12-11 | 2003-09-15 | Iaf Biochem Int | Antivirale verbindungen |
WO2000050424A1 (en) * | 1999-02-22 | 2000-08-31 | Biochem Pharma Inc. | [1,8] naphthyridine derivatives having antiviral activity |
DE19912638A1 (de) * | 1999-03-20 | 2000-09-21 | Bayer Ag | Naphthylcarbonsäureamid-substituierte Sulfonamide |
US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6562822B2 (en) | 2000-07-12 | 2003-05-13 | Pharmacia & Upjohn Company | Heterocyle carboxamides as antiviral agents |
WO2002051413A2 (en) * | 2000-12-27 | 2002-07-04 | Shire Biochem Inc. | Macrocyclic anti-viral compounds |
US7005434B2 (en) | 2001-01-19 | 2006-02-28 | Sb Corporation | Compounds and uses thereof |
JP4795022B2 (ja) * | 2003-09-30 | 2011-10-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環化合物を含有する新規な抗真菌剤 |
WO2007060028A1 (en) * | 2004-12-31 | 2007-05-31 | Gpc Biotech Ag | Napthyridine compounds as rock inhibitors |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
WO2008035726A1 (fr) | 2006-09-21 | 2008-03-27 | Eisai R & D Management Co., Ltd. | Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant |
CA2685194A1 (en) | 2007-04-27 | 2008-11-13 | Eisai R&D Management Co., Ltd. | Heterocycle-substituted pyridine derivatives salt or crystal thereof |
TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
US8258301B2 (en) * | 2007-05-15 | 2012-09-04 | Boehringer Ingelheim International Gmbh | Urotensin II receptor antagonists |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
EP2922540A1 (en) | 2012-11-20 | 2015-09-30 | F. Hoffmann-La Roche AG | Substituted 1,6-naphthyridines |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4786644A (en) * | 1987-11-27 | 1988-11-22 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinolinecarboxamide |
JPH02237922A (ja) * | 1989-01-24 | 1990-09-20 | Green Cross Corp:The | 抗ウィルス剤 |
WO1990013542A1 (fr) * | 1989-04-28 | 1990-11-15 | Daiichi Pharmaceutical Co., Ltd. | Medicament anti-hiv |
US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
US5516784A (en) * | 1991-08-13 | 1996-05-14 | Schering Corporation | Anti-HIV (AIDS) agents |
AU5447094A (en) * | 1992-10-21 | 1994-05-09 | Regents Of The University Of Michigan, The | Polysubstituted benzimidazoles as antiviral agents |
DE4303657A1 (de) * | 1993-02-09 | 1994-08-11 | Bayer Ag | Neue Chinolon- und Naphthyridoncarbonsäurederivate |
DE4331135A1 (de) * | 1993-09-14 | 1995-03-16 | Bayer Ag | Neue antiviral wirksame valinhaltige Pseudopeptide |
US5543413A (en) * | 1994-02-25 | 1996-08-06 | Regents Of The University Of Michigan | Heterocyclic thioamides and related analogs as antiviral agents with a unique mode of action |
EP0784470B1 (en) * | 1994-10-03 | 2003-08-13 | INFECTIO RECHERCHE Inc. | Liposome-formulations for treatment of viral diseases |
DE69631423T2 (de) * | 1995-08-02 | 2004-12-02 | Darwin Discovery Ltd., Slough | Chinolone und deren therapeutische verwendung |
-
1996
- 1996-03-15 GB GBGB9605437.4A patent/GB9605437D0/en active Pending
-
1997
- 1997-03-14 WO PCT/CA1997/000182 patent/WO1997034894A1/en active IP Right Grant
- 1997-03-14 DE DE69727838T patent/DE69727838D1/de not_active Expired - Lifetime
- 1997-03-14 AU AU19187/97A patent/AU722650B2/en not_active Ceased
- 1997-03-14 CA CA002250320A patent/CA2250320A1/en not_active Abandoned
- 1997-03-14 BR BR9708068-3A patent/BR9708068A/pt unknown
- 1997-03-14 GB GB9819782A patent/GB2326412A/en not_active Withdrawn
- 1997-03-14 CN CN97194535A patent/CN1069643C/zh not_active Expired - Fee Related
- 1997-03-14 EP EP97906955A patent/EP0984967B1/en not_active Expired - Lifetime
- 1997-03-14 JP JP53299797A patent/JP2001515464A/ja active Pending
- 1997-03-14 AT AT97906955T patent/ATE260279T1/de not_active IP Right Cessation
- 1997-03-17 ZA ZA9702292A patent/ZA972292B/xx unknown
- 1997-03-19 TW TW086103467A patent/TW480258B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0984967A1 (en) | 2000-03-15 |
JP2001515464A (ja) | 2001-09-18 |
CN1218473A (zh) | 1999-06-02 |
GB9605437D0 (en) | 1996-05-15 |
CA2250320A1 (en) | 1997-09-25 |
ATE260279T1 (de) | 2004-03-15 |
BR9708068A (pt) | 2000-01-04 |
EP0984967B1 (en) | 2004-02-25 |
GB2326412A (en) | 1998-12-23 |
DE69727838D1 (de) | 2004-04-01 |
TW480258B (en) | 2002-03-21 |
GB9819782D0 (en) | 1998-11-04 |
CN1069643C (zh) | 2001-08-15 |
AU1918797A (en) | 1997-10-10 |
AU722650B2 (en) | 2000-08-10 |
WO1997034894A1 (en) | 1997-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA972292B (en) | Cytomegalovirus inhibiting compounds. | |
EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
HK1033463A1 (en) | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents | |
ATE249219T1 (de) | Antivirale verbindungen | |
MX9700430A (es) | El uso de compuestos heterociclicos. | |
MY111201A (en) | New imidazopyridines | |
MY109002A (en) | Amino-substituted pyrrazoles. | |
AU6783698A (en) | Polyaromatic antiviral compositions | |
IL158667A0 (en) | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections | |
AU2291097A (en) | Novel phenanthridines substituted in the 6 position | |
YU19499A (sh) | Benzonaftiridini kao bronhijalni terapeutici | |
CA2114727A1 (en) | Quinoline Derivatives as Immunostimulants | |
JO1704B1 (en) | New potent compounds | |
SI1042319T1 (en) | Dihydrobenzofurans | |
MX9801190A (es) | Inhibidores de prolil endopeptidasa. | |
CA2166692A1 (en) | Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines | |
CA2144344A1 (en) | Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents | |
ZA9410287B (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines | |
WO2002051413A3 (en) | Macrocyclic anti-viral compounds | |
NO972905L (no) | Tienoksasinon-derivater anvendelige som antivirusmidler | |
HU9601498D0 (en) | Use of dimeticone for treating constipation | |
ZA983231B (en) | Substituted benzyloxyimino compounds. | |
MY106961A (en) | Antiviral tetrahydroimidazo[1,4] benzodiazepines | |
PH31255A (en) | Use of triazine compounds as anxiolytics. | |
CA2206804A1 (en) | Trisubstituted thioxanthines |